NCT04078126View on ClinicalTrials.gov

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

PHASE3CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
COMBINATION_PRODUCT

BFF

Treatment with budesonide and formoterol furmate MDI (metered-dose inhaler)

COMBINATION_PRODUCT

Symbicort Turbuhaler

Treatment with budesonide and formoterol furmate DPI (dry-powder inhaler)

Trial Locations (4)

60389

Research Site, Frankfurt am Main

82131

Research Site, Gauting

86899

Research Site, Landsberg

D-30173

Research Site, Hanover

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY